🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics

RecruitingNAAges 50 Years - 77 YearsAllRutgers, The State University of New Jersey
NCT07165691 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Aim 1: Culturally adapt the TELESCOPE intervention for Hispanics. Using iterative qualitative feedback from a study-specific Community Advisory Board, focus groups, and interviews with community members, the investigators will culturally adapt the TELESCOPE intervention for Hispanics at high risk for lung cancer. Aim 2: Assess the feasibility, acceptability, and implementation potential of the culturally adapted TELESCOPE intervention delivered by bilingual patient navigators for Hispanics. Hypothesis 1: The investigators expect a recruitment rate of ≥60%, ≥90% of Hispanic participants will complete the 1-week follow-up assessments, ≥80% of the key intervention components will be delivered with 80% fidelity by the patient navigators, and ≥90% of participants and clinicians will agree or completely agree that the intervention was feasible and acceptable. Aim 3: Explore the impact of a c

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Aim 1 (Cultural Adaptation): To be eligible, patients must: 1. Identify as Hispanic and/or Latino(a) 2. Able to read and speak in English or Spanish 3. Be 50 to 77 years of age 4. Be a current or former smoker 5. Have at least a 20-pack-year smoking history Aims 2-3 (Pilot Randomized Controlled Trial) To be eligible, patients must: * Identify as Hispanic or Latino(a) * Able to speak and read in English or Spanish * Be 50 to 77 years of age * Be a current or former smoker having quit within the past 15 years * Have at least a 20 pack-year smoking history * Be scheduled for a non-acute care visit at one of the study sites. * Not coughing up blood in the last two weeks Interviews Providers completing the semi-structured interviews will be: * A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator at one of the participating sites, or a TELESCOPE study patient navigator and nurse navigator * Age 18 or older * Fluent in English Online surveys Providers completing online PRISM construct surveys will be: * A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator * Age 18 or older * Fluent in English Exclusion Criteria: For the cluster randomized trial, excluded will be patients who: * Do not speak English * Are not Hispanic or Latino(a) * Have a history of lung cancer * Had a CT scan in the past 12 months * Has been coughing up blood in the last two weeks * Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider, * Are unable to provide informed consent Interviews Providers/administrators will be excluded if they: * Are unable to provide informed consent Online surveys * Are unable to provide informed consent * Women who are pregnant.
💊

What it tests

  • TELESCOPE, Remote Decision Coaching with Navigation Intervention
📍

Where

1 site
Rutgers Cancer Institute
New Brunswick, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy